The growth of the EPS is critical in understanding the current valuation of Fonar Corporation. It is usually expressed as a percentage and is then referred to as the EPS growth rate, which at this time is hard to estimate, but revenue growth has been 3.80% over the last twelve months. Growth in EPS is an important measure of administration performance because it shows how much money Fonar Corporation is making for it’s investors or shareholders.
Fonar Corporation is in the medical devices industry and is in the healthcare sector. The company CEO is Timothy R. Damadian. Fonar Corp is engaged in the research, development, production and marketing of medical scanning equipment. The Company operates in two segments manufacturing and servicing of medical equipment and management of diagnostic imaging centers.
Previous Intraday Performance:
The FONR stock had a previous change of 1.51% which opened at 22.02 and closed at 22.13. It moved to an intraday high of 23.02 and a low of 21.83.
SeekingAlpha: Fonar reports Q1 results
Historical Performance:
Over the last five trading days, FONR shares returned -12.32% and in the past 30 trading days it returned -5.83%. Over three months, it changed -17.58%. In one year it has changed -6.82% and within that year its 52-week high was 30.10 and its 52-week low was 21.20. FONR stock is 4.39% above its 52 Week Low.
Our calculations result in a 200 day moving average of 26.13 and a 50 day moving average of 24.02. Right now, FONR stock is trading -15.30% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.
SeekingAlpha: Fonar reports Q1 results
Liquidity:
The company has a market cap of $143.5m with 6.5m shares outstanding and a float of 6.4m shares. Trading volume was 22,321 shares and has experienced an average volume of 25,764 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
Earnings:
The last annual reported EPS for Fonar Corporation was 3.1 which ended on 30th of June 2018, which according to the previous close, that is a PE of 7.14.
Below was the last reported quarterly earnings per share:
09-30-2018: 0.48
06-30-2018: 1.44
03-31-2018: 0.51
12-31-2017: 0.70
Base on our calculations, the intrinsic value per share is 26.45, which means it might be undervalued and has a margin of safety of 16.34%
Additional Indicators:
Based on the latest filings, there is 46.40% of institutional ownership.
I calculated the beta to be 1.11
SeekingAlpha: More on Gladstone Capital Q4
Fundamentals:
Based on last reported financials, the company’s return on equity is 21.19%, return on assets is 17.72%, profit margin is 29.95%, price-to-sales is 1.85 and price-to-book is 1.48.
Analysis Rank:
Results are out of six:
0 : Growth Expectations Result
6 : Financial Safety Result
3 : Past Performance Result
3 : Valuation Result
0 : Dividend Safety Result
3 : Overall Result
Related
